Literature DB >> 25644508

Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review.

Konstantinos A Zorbas1, Konstantinos P Economopoulos, Nikos F Vlahos.   

Abstract

PURPOSE: Recurrence of endometriosis after conservative surgery has been observed in 40-50 % of patients within the first 5 years. A variety of regimens such as combined oral contraceptives, GnRH agonists, danazol, and progestins have been used postoperatively to reduce recurrence rates. Oral contraceptives (oCP) have been used either in a cyclic or in a continuous (no pill-free interval) fashion. The purpose of this article was to summarize the existing evidence on the efficacy and patient compliance for the use of oCP in a continuous versus cyclic fashion following conservative surgery for endometriosis.
METHODS: A systematic search of Medline identified four eligible studies. Studies were considered eligible, if they have evaluated oCP therapy, either in a cyclic or continuous regimen, after conservative surgery for endometriosis. Specifically, studies (1) reporting on women with endometriosis who were treated postoperatively with both continuous oCP and cyclic oCP, (2) written in English, (3) with minimum 6 months duration of medical treatment, and (4) with minimum 12 months duration of follow-up were considered eligible for our systematic review. Outcome measures of these eligible studies were tabulated and then analyzed cumulatively. A purely descriptive approach was adopted concerning all variables.
RESULTS: Postoperative use of continuous oCP was associated with a reduction in the recurrence rate of dysmenorrhea, delay in the presentation of dysmenorrhea, reduction in nonspecific pelvic pain, and reduction in the recurrence rate for endometrioma.
CONCLUSIONS: Use of oCP in a continuous fashion following conservative surgery for endometriosis is more beneficial to cyclic use.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25644508     DOI: 10.1007/s00404-015-3641-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  9 in total

Review 1.  Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.

Authors:  Lori M Gawron; Jessica Sanders; Katelyn P Steele; Ann D Flynn
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 2.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

3.  Medical Management of Endometriosis.

Authors:  Saima Rafique; Alan H Decherney
Journal:  Clin Obstet Gynecol       Date:  2017-09       Impact factor: 2.190

4.  Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020).

Authors:  Stefanie Burghaus; Sebastian D Schäfer; Matthias W Beckmann; Iris Brandes; Christian Brünahl; Radek Chvatal; Jan Drahoňovský; Wojciech Dudek; Andreas D Ebert; Christine Fahlbusch; Tanja Fehm; Peter Martin Fehr; Carolin C Hack; Winfried Häuser; Katharina Hancke; Volker Heinecke; Lars-Christian Horn; Christian Houbois; Christine Klapp; Heike Kramer; Harald Krentel; Jan Langrehr; Heike Matuschewski; Ines Mayer; Sylvia Mechsner; Andreas Müller; Armelle Müller; Michael Müller; Peter Oppelt; Thomas Papathemelis; Stefan P Renner; Dietmar Schmidt; Andreas Schüring; Karl-Werner Schweppe; Beata Seeber; Friederike Siedentopf; Horia Sirbu; Daniela Soeffge; Kerstin Weidner; Isabella Zraik; Uwe Andreas Ulrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

Review 5.  Hormonal treatments for endometriosis: The endocrine background.

Authors:  Silvia Vannuccini; Sara Clemenza; Margherita Rossi; Felice Petraglia
Journal:  Rev Endocr Metab Disord       Date:  2021-08-17       Impact factor: 9.306

6.  Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial.

Authors:  Mingxiao Yang; Xiangzhu Chen; Linna Bo; Lixing Lao; Jiao Chen; Siyi Yu; Zheng Yu; Hongzhi Tang; Ling Yi; Xi Wu; Jie Yang; Fanrong Liang
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

7.  Does the Use of the "Proseek® Multiplex Oncology I Panel" on Peritoneal Fluid Allow a Better Insight in the Pathophysiology of Endometriosis, and in Particular Deep-Infiltrating Endometriosis?

Authors:  Alexandra Perricos; René Wenzl; Heinrich Husslein; Thomas Eiwegger; Manuela Gstoettner; Andreas Weinhaeusel; Gabriel Beikircher; Lorenz Kuessel
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

8.  An Update on Contraception in Polycystic Ovary Syndrome.

Authors:  Seda Hanife Oguz; Bulent Okan Yildiz
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-15

Review 9.  Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis.

Authors:  Masaru Iwata; Yoshihiro Oikawa; Yutaka Shimizu; Naotaka Sakashita; Ayako Shoji; Ataru Igarashi; Yutaka Osuga
Journal:  Adv Ther       Date:  2022-09-01       Impact factor: 4.070

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.